{"gene":"SLC26A4","run_date":"2026-04-28T20:42:07","timeline":{"discoveries":[{"year":1999,"finding":"Mouse ortholog Pds (Slc26a4) is expressed in the endolymphatic duct and sac, distinct areas of the utricle and saccule, and the external sulcus region of the cochlea—regions implicated in endolymphatic fluid resorption—establishing a key role for pendrin in inner ear fluid homeostasis.","method":"RNA in situ hybridization on mouse inner ears across developmental stages","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — direct localization experiment with functional consequence (endolymphatic fluid resorption), widely cited foundational study","pmids":["10449762"],"is_preprint":false},{"year":2003,"finding":"Pendrin (Slc26a4) is expressed on the apical plasma membrane of type B and non-A, non-B intercalated cells in the kidney collecting duct; deoxycorticosterone (DOCP) upregulates Pds mRNA (~60%) and apical pendrin protein (2–6-fold), and Pds-null mice fail to develop DOCP-induced hypertension or metabolic alkalosis, demonstrating that pendrin is required for mineralocorticoid-induced NaCl retention and blood pressure elevation.","method":"Quantitative RT-PCR, immunolocalization (light and electron microscopy), and physiological studies in Pds(-/-) mice treated with DOCP","journal":"Hypertension","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (molecular, protein, and whole-animal physiology) in knockout model with defined phenotypic readout","pmids":["12925556"],"is_preprint":false},{"year":2005,"finding":"Genetic disruption of Slc26a4 in mice reduces the abundance of non-A (type B and non-A, non-B) intercalated cells and decreases H⁺-ATPase, NBC3, and RhBG protein expression in the cortical collecting duct, indicating that pendrin-mediated HCO₃⁻ secretion controls intercalated cell subtype composition and H⁺/OH⁻ transporter expression to maintain acid-base balance.","method":"Balance studies, immunolocalization, and immunoblotting in Slc26a4(-/-) mice","journal":"American Journal of Physiology – Renal Physiology","confidence":"High","confidence_rationale":"Tier 2 — knockout with multiple orthogonal methods and defined cellular phenotype","pmids":["16144965"],"is_preprint":false},{"year":2006,"finding":"Pendrin (SLC26A4) mediates Cl⁻/I⁻ anion exchange across the plasma membrane; the disease-associated S28R mutant shows markedly reduced Cl⁻/I⁻ transport activity compared with wild-type pendrin.","method":"Fast fluorometric Cl⁻/I⁻ transport assay in heterologously expressing cells","journal":"Cellular Physiology and Biochemistry","confidence":"Medium","confidence_rationale":"Tier 1 — in vitro transport assay with mutant, but single study","pmids":["16914891"],"is_preprint":false},{"year":2007,"finding":"A c.−103T→C mutation in the SLC26A4 promoter abolishes FOXI1 binding and eliminates FOXI1-mediated transcriptional activation of SLC26A4; mutations in FOXI1 also compromise its ability to activate SLC26A4; double-heterozygous Slc26a4(+/−); Foxi1(+/−) mice develop EVA, establishing a dosage-dependent transcriptional regulatory pathway for SLC26A4.","method":"Reporter assays, electrophoretic mobility shift assay (FOXI1 binding), mouse double-heterozygous model with EVA phenotype readout","journal":"American Journal of Human Genetics","confidence":"High","confidence_rationale":"Tier 1–2 — transcriptional mechanism validated by binding assay + mouse genetics with defined phenotype","pmids":["17503324"],"is_preprint":false},{"year":2008,"finding":"Most disease-associated SLC26A4 missense mutations cause retention of pendrin in the endoplasmic reticulum or centrosomal region, abolishing complex glycosylation and Cl⁻/HCO₃⁻ exchange activity; temperature rescue (low temperature) restores processing of H723R-pendrin but not L236P-pendrin, demonstrating mutation-specific folding defects.","method":"Cellular localization (immunofluorescence/fractionation), N-glycosylation assays, Cl⁻/HCO₃⁻ exchange activity assays, low-temperature rescue experiments","journal":"Journal of Medical Genetics","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods (localization, glycosylation, transport function, rescue), replicated across multiple mutants","pmids":["18310264"],"is_preprint":false},{"year":2008,"finding":"Functional characterization of SLC26A4 missense mutations in Xenopus oocytes revealed that addition or loss of proline or charged amino acids is detrimental to pendrin ion transport function; the E303Q mutant, despite near-normal surface expression, completely abolishes anion exchange activity, while F354S and E737D mutations selectively reduce Cl⁻/HCO₃⁻ exchange relative to Cl⁻/Cl⁻ and Cl⁻/I⁻ exchange.","method":"Anion exchange activity measured in Xenopus oocytes; surface expression quantification","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — reconstituted functional assay in oocytes with multiple mutants and surface expression controls","pmids":["19017801"],"is_preprint":false},{"year":2008,"finding":"Two Tunisian disease-associated SLC26A4 mutations (L445W and M147T) abolish complex glycosylation of pendrin and prevent its trafficking to the plasma membrane, trapping it in an intracellular compartment.","method":"RT-PCR, western blot, and immunofluorescence in COS7 cells and thyroid 8305C cells transfected with wild-type or mutant SLC26A4","journal":"Clinical Genetics","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods (protein level, glycosylation, localization) in a single study","pmids":["20128824"],"is_preprint":false},{"year":2008,"finding":"Carbonic anhydrase II (CAII) deficiency reduces pendrin (Slc26a4) mRNA and protein expression in kidney cortex by ~63%, demonstrating that CAII is required for maintenance of pendrin expression in intercalated cells.","method":"Real-time RT-PCR, Northern hybridization, immunolabeling, and immunoblotting in CAII-null mice","journal":"Cellular Physiology and Biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 — multiple molecular methods in knockout model, single study","pmids":["18209476"],"is_preprint":false},{"year":2008,"finding":"A novel frameshift SLC26A4 mutation (c.1458_1459insT) produces a protein mislocalized to the ER rather than the plasma membrane in COS7 cells, as shown by YFP-fusion live imaging.","method":"Fluorescent protein (YFP) construct transfection in COS7 cells with live imaging","journal":"Archives of Otolaryngology – Head & Neck Surgery","confidence":"Low","confidence_rationale":"Tier 3 — single method, single study, single mutation","pmids":["18427006"],"is_preprint":false},{"year":2009,"finding":"Pendrin (SLC26A4) functions as a transmembrane exchanger of Cl⁻, I⁻, and HCO₃⁻; functional assays of missense mutations confirmed that most disease alleles substantially reduce anion transport, with the severity correlating with structural changes such as proline insertion/deletion or charge alterations.","method":"Radioisotope-based transport assays and confocal microscopy for membrane expression in heterologous expression system","journal":"Journal of Molecular Endocrinology","confidence":"Medium","confidence_rationale":"Tier 1–2 — functional transport assays across multiple mutants, summary of multiple studies","pmids":["19608655"],"is_preprint":false},{"year":2011,"finding":"In Slc26a4-null mice, pendrin-mediated luminal Cl⁻/HCO₃⁻ exchange is the exclusive apical bicarbonate-secreting pathway in type B intercalated cells; its expression and activity are regulated by systemic acid-base status, dietary chloride, angiotensin II, and aldosterone through changes in subcellular localization, cell abundance, and total protein level.","method":"Genetic ablation (Slc26a4 knockout mouse), immunolocalization, and acid-base physiological studies","journal":"Cellular Physiology and Biochemistry","confidence":"High","confidence_rationale":"Tier 2 — knockout with defined cellular phenotype, multiple regulatory mechanisms established, replicated across labs","pmids":["22116363"],"is_preprint":false},{"year":2012,"finding":"Most SLC26A4 variant pendrins tested in Chinese patients with EVA cause retention of the protein in intracellular compartments rather than delivery to the plasma membrane, resulting in significantly reduced anion transport capability.","method":"Confocal microscopy for membrane expression and radioisotope transport assays in heterologous expression system","journal":"PLoS One","confidence":"Medium","confidence_rationale":"Tier 1–2 — functional transport and localization assays across 10 variants, single lab","pmids":["23185506"],"is_preprint":false},{"year":2013,"finding":"Restoration of SLC26A4/pendrin expression specifically in the endolymphatic sac (using ATP6V1B1 promoter-driven transgene) is sufficient to rescue normal endocochlear potential, pH gradients, otoconia formation, and hearing and balance in Slc26a4-null mice, demonstrating that pendrin activity in the endolymphatic sac is the critical site for inner ear development.","method":"Transgenic mouse complementation (endolymphatic sac-targeted expression in Slc26a4(Δ/Δ) background), auditory/vestibular physiology, endocochlear potential measurements, pH measurements, immunohistochemistry","journal":"PLoS Genetics","confidence":"High","confidence_rationale":"Tier 2 — rigorous gain-of-function rescue in KO mice with multiple physiological readouts","pmids":["23874234"],"is_preprint":false},{"year":2013,"finding":"In embryonic Slc26a4(Δ/Δ) cochlea, endolymph is initially Na⁺-rich (~141 mM) and transitions to K⁺-rich fluid before birth; pendrin loss delays this K⁺ rise by ~3 days, linking disrupted Na⁺ transport to endolymphatic sac enlargement.","method":"Double-barreled ion-selective electrode measurements of endolymph Na⁺ and K⁺, quantitative RT-PCR and immunohistochemistry for ion transporters in Slc26a4(Δ/Δ) vs. Slc26a4(Δ/+) mice","journal":"PLoS One","confidence":"Medium","confidence_rationale":"Tier 2 — direct ion measurement in KO vs. heterozygous mice with transporter expression data; single lab","pmids":["23741519"],"is_preprint":false},{"year":2013,"finding":"Residual anion exchange activity and surface expression ratio of pendrin are higher for the T410M mutant than the H723R mutant; patients with c.919-2A>G homozygous mutations produce a small amount of normal pendrin transcript (6–17% of normal), and these differences correlate with better residual hearing, establishing a genotype–function–phenotype relationship.","method":"Quantitative PCR for transcript levels, surface expression ratio assay, anion exchange activity assay in transfected cells","journal":"Clinical Genetics","confidence":"Medium","confidence_rationale":"Tier 2 — functional assays correlating with clinical phenotype, single lab","pmids":["24007330"],"is_preprint":false},{"year":2014,"finding":"Slc26a4-insufficient mice (with limited embryonic pendrin expression then withdrawn) develop fluctuating hearing loss and degeneration of stria vascularis intermediate cells, with hearing threshold fluctuations correlating with endocochlear potential fluctuations, establishing that pendrin insufficiency causes stria vascularis dysfunction and fluctuating hearing.","method":"Doxycycline-controlled transgenic mouse model, auditory brainstem response, endocochlear potential measurements, histology of stria vascularis","journal":"Neurobiology of Disease","confidence":"High","confidence_rationale":"Tier 2 — controlled hypomorphic mouse model with direct electrophysiological and histological readouts","pmids":["24561068"],"is_preprint":false},{"year":2019,"finding":"A systematic doxycycline dosage-dependent transport assay in HEK293T stable lines expressing pendrin missense variants in a 96-well format quantitatively distinguished loss-of-function from functional variants; several putative missense variants were found to disrupt mRNA splicing rather than protein function directly.","method":"Stable HEK293T cell lines with doxycycline-inducible expression of pendrin variants; high-throughput anion transport assay; splicing analysis","journal":"Human Mutation","confidence":"High","confidence_rationale":"Tier 1 — systematic reconstitution and functional assay across many variants with doxycycline dose-response","pmids":["31599023"],"is_preprint":false},{"year":2019,"finding":"Local gene delivery (viral vector with Slc26a4 cDNA) to embryonic day 12.5 otocysts of Slc26a4 knockout and knock-in mice restored hearing but not vestibular function, demonstrating distinct spatial requirements for pendrin in cochlear vs. vestibular development.","method":"Recombinant viral vector-mediated otocyst transfection, auditory brainstem response, vestibular function testing in pendrin-deficient mice","journal":"Theranostics","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo gene therapy in KO/KI mice with defined functional readouts, single lab","pmids":["31695761"],"is_preprint":false},{"year":2019,"finding":"Modified U1 snRNA rescues aberrant splicing caused by 11 of 17 SLC26A4 splice-site mutations tested in minigene assays; for three cryptic splice mutations, co-application of modified U1 snRNA and antisense oligonucleotides restored normal splicing, demonstrating that these mutations disrupt U1 snRNA recognition at 5' splice donor sites.","method":"Minigene splicing assays, modified U1 snRNA transfection, antisense oligonucleotide rescue experiments","journal":"Human Mutation","confidence":"Medium","confidence_rationale":"Tier 1–2 — functional splicing assays with mechanistic rescue across multiple mutations, single lab","pmids":["31033086"],"is_preprint":false},{"year":2019,"finding":"The chaperonin DNAJC14, activated via JEV inoculation in vitro, rescues surface expression and anion exchange activity of H723R-pendrin; DNAJC14 overexpression in H723R-pendrin transgenic mice reduces cochlear hydrops and preserves outer hair cells and stria vascularis thickness with increased KCNJ10 expression, confirming that H723R causes a protein-folding defect correctable by chaperone upregulation.","method":"In vitro DNAJC14 activation assay, H723R-pendrin transgenic mice crossed with DNAJC14-overexpressing mice, cochlear histology, KCNJ10 immunostaining","journal":"Molecular Therapy: Methods & Clinical Development","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro and in vivo rescue experiments with defined molecular and cellular readouts, single lab","pmids":["31909090"],"is_preprint":false},{"year":2020,"finding":"EphA2 forms a protein complex with pendrin and controls pendrin's subcellular localization; this interaction is disrupted by pathogenic pendrin mutations. Digenic mutations in EPHA2 (causing amino acid substitutions) in combination with monoallelic SLC26A4 mutations cause Pendred syndrome; EphA2 mutants attenuate ephrin-B2-triggered internalization of pendrin while sparing ephrin-A1-induced internalization.","method":"Co-immunoprecipitation (pendrin–EphA2 complex), subcellular localization studies, patient mutation identification, ephrin ligand stimulation assays","journal":"Nature Communications","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP establishing complex, functional localization assay, patient genetics, multiple orthogonal methods","pmids":["32165640"],"is_preprint":false},{"year":2021,"finding":"AT2 cell-specific deletion of RhoA upregulates Slc26a4 (pendrin) expression in mouse lungs; SLC26A4 upregulation is also found in AT2 cells of asthmatic patients and in human airway epithelial cells expressing dominant-negative RHOA; SLC26A4 inhibition promotes epithelial TGF-β1 release and attenuates allergic airway inflammation, placing SLC26A4 downstream of RhoA in a pathway controlling TGF-β1 secretion and airway inflammation.","method":"Conditional AT2-specific RhoA KO mice, allergen challenge model, RNA sequencing, dominant-negative RHOA overexpression in human cells, SLC26A4 inhibition experiments","journal":"JCI Insight","confidence":"Medium","confidence_rationale":"Tier 2 — genetic epistasis via conditional KO plus human cell mechanistic follow-up, single lab","pmids":["34101619"],"is_preprint":false},{"year":2022,"finding":"Slc26a7-null mice show goitrous congenital hypothyroidism and marked growth failure; Slc26a4-null mice show no growth failure or hypothyroidism under low-iodine conditions; double-deficient mice are more severely affected than Slc26a7-null mice, and RNA-seq shows far more differentially expressed genes in Slc26a7-null than Slc26a4-null thyroid, demonstrating that SLC26A7 is the dominant iodide transporter for thyroid function while SLC26A4 plays a secondary role.","method":"Slc26a4-null, Slc26a7-null, and double-null mouse models under normal and low-iodine diet; growth/hormone measurements; RNA-seq","journal":"Scientific Reports","confidence":"High","confidence_rationale":"Tier 2 — systematic comparison across single and double KO mice with physiological and transcriptomic readouts","pmids":["35788623"],"is_preprint":false}],"current_model":"SLC26A4 (pendrin) is a membrane anion exchanger (Cl⁻/HCO₃⁻/I⁻) localized to the apical membrane of thyroid follicular cells, renal type B and non-A/non-B intercalated cells, and endolymphatic sac/cochlear epithelium; its activity in the endolymphatic sac is required for normal endolymph Na⁺→K⁺ transition and inner ear development, its transcription is controlled by FOXI1 binding to a promoter element, its subcellular trafficking is regulated by EphA2 and chaperones such as DNAJC14, and most pathogenic mutations cause ER retention/misfolding that abolishes anion transport, leading to hearing loss (DFNB4/Pendred syndrome) and, in the kidney, impaired mineralocorticoid-induced NaCl retention and blood pressure regulation."},"narrative":{"teleology":[{"year":1999,"claim":"Establishing where pendrin acts in the inner ear resolved why SLC26A4 mutations cause hearing loss: expression mapped to the endolymphatic duct/sac and cochlear external sulcus—sites of endolymph resorption—linking the transporter to fluid homeostasis rather than sensory transduction per se.","evidence":"RNA in situ hybridization across developmental stages in mouse inner ears","pmids":["10449762"],"confidence":"High","gaps":["No functional transport data at this stage","Expression in non-inner-ear tissues not yet characterized"]},{"year":2003,"claim":"Demonstrating that Pds-null mice resist mineralocorticoid-induced hypertension and metabolic alkalosis established a renal role for pendrin distinct from its inner ear function: pendrin mediates apical Cl⁻/HCO₃⁻ exchange in type B intercalated cells and is required for NaCl retention.","evidence":"Quantitative RT-PCR, immunolocalization, and blood pressure/electrolyte physiology in DOCP-treated Pds−/− mice","pmids":["12925556"],"confidence":"High","gaps":["Upstream signals controlling renal pendrin abundance not yet defined","Whether pendrin contributes to basal (non-mineralocorticoid) blood pressure unknown"]},{"year":2005,"claim":"Showing that Slc26a4 knockout alters intercalated cell subtype composition and expression of H⁺-ATPase, NBC3, and RhBG revealed that pendrin-mediated HCO₃⁻ secretion is not merely one of several pathways but the dominant apical bicarbonate exit route whose loss remodels collecting duct cell identity.","evidence":"Immunoblotting, immunolocalization, and balance studies in Slc26a4−/− mice","pmids":["16144965"],"confidence":"High","gaps":["Signaling mechanism linking loss of luminal HCO₃⁻ to intercalated cell remodeling unknown","Whether human CKD patients show analogous cell-type shifts unexplored"]},{"year":2006,"claim":"Direct measurement of Cl⁻/I⁻ exchange in heterologous cells confirmed pendrin as a bona fide anion exchanger and showed the first disease-associated mutant (S28R) with quantifiably reduced transport, establishing the functional assay framework used in subsequent studies.","evidence":"Fast fluorometric Cl⁻/I⁻ transport assay in transfected cells","pmids":["16914891"],"confidence":"Medium","gaps":["Only one mutant tested","Cl⁻/HCO₃⁻ exchange not measured in this assay"]},{"year":2007,"claim":"Identification of FOXI1 as a transcription factor that binds the SLC26A4 promoter and is required for its expression, together with EVA in double-heterozygous mice, resolved how monoallelic SLC26A4 mutations can cause disease through digenic dosage-dependent transcriptional insufficiency.","evidence":"EMSA for FOXI1 binding, reporter assays, Slc26a4+/−;Foxi1+/− double-heterozygous mice with EVA phenotype","pmids":["17503324"],"confidence":"High","gaps":["Other transcription factors acting on SLC26A4 not identified","Whether FOXI1 dosage explains all monoallelic SLC26A4 cases unknown"]},{"year":2008,"claim":"Systematic analysis of disease-associated missense mutations revealed that the dominant pathogenic mechanism is ER retention and misfolding rather than catalytic-site inactivation, with mutation-specific rescue by low temperature indicating correctable folding defects; a subset of mutations (e.g., E303Q) reach the surface but are catalytically dead, separating trafficking from transport competence.","evidence":"Immunofluorescence, N-glycosylation analysis, Cl⁻/HCO₃⁻ exchange assays, low-temperature rescue in transfected cells; anion exchange in Xenopus oocytes with surface expression quantification","pmids":["18310264","19017801"],"confidence":"High","gaps":["Structural basis for folding defects unknown (no crystal structure)","Endogenous chaperones involved not yet identified","Whether ER-retained pendrin triggers UPR or is degraded by ERAD not tested"]},{"year":2011,"claim":"Integrating knockout physiology with hormonal regulation demonstrated that pendrin expression and apical targeting in kidney are dynamically controlled by aldosterone, angiotensin II, dietary Cl⁻, and acid–base status, positioning pendrin as a regulated effector of systemic electrolyte balance rather than a constitutive transporter.","evidence":"Slc26a4 KO mice with immunolocalization and acid–base physiological studies under varied conditions","pmids":["22116363"],"confidence":"High","gaps":["Direct kinase/phosphatase cascades linking aldosterone/AngII to pendrin trafficking not identified","Post-translational modifications regulating pendrin unclear"]},{"year":2013,"claim":"Targeted restoration of pendrin solely in the endolymphatic sac rescued hearing, balance, endocochlear potential, and otoconia in Slc26a4-null mice, proving that the endolymphatic sac—not the cochlea or vestibule—is the critical site of pendrin action for inner ear development, and that pendrin controls the embryonic Na⁺-to-K⁺ endolymph composition switch.","evidence":"Transgenic complementation (Atp6v1b1-promoter-driven Slc26a4) in null mice; endocochlear potential, pH, ion-selective electrode measurements","pmids":["23874234","23741519"],"confidence":"High","gaps":["Mechanism by which endolymphatic sac pendrin remotely controls cochlear endolymph composition unclear","Identity of downstream ion transporters affected in endolymphatic sac not fully catalogued"]},{"year":2014,"claim":"A doxycycline-controlled hypomorphic model showed that even partial pendrin insufficiency causes fluctuating hearing loss correlated with endocochlear potential instability and stria vascularis degeneration, explaining the clinical fluctuating phenotype in patients with residual SLC26A4 function.","evidence":"Doxycycline-regulated Slc26a4 transgenic mice; ABR, endocochlear potential, stria vascularis histology","pmids":["24561068"],"confidence":"High","gaps":["Threshold of pendrin activity needed to prevent fluctuating hearing loss not quantified","Whether stria vascularis degeneration is reversible unknown"]},{"year":2019,"claim":"Multiple complementary advances addressed therapeutic correction: high-throughput functional classification of variants distinguished loss-of-function from benign alleles; modified U1 snRNA rescued splicing defects caused by 11/17 splice-site mutations; chaperone DNAJC14 overexpression rescued H723R-pendrin folding, surface expression, and cochlear pathology in vivo; and embryonic otocyst gene delivery restored hearing in KO mice.","evidence":"Doxycycline-inducible HEK293T transport assay across many variants; minigene splicing assays with U1/ASO rescue; DNAJC14-overexpressing transgenic cross with H723R mice; viral vector otocyst injection with ABR","pmids":["31599023","31033086","31909090","31695761"],"confidence":"Medium","gaps":["DNAJC14 mechanism of pendrin folding rescue not defined at structural level","Gene therapy did not rescue vestibular function—spatial requirements for vestibular rescue unclear","Long-term durability of gene therapy or chaperone approaches unknown"]},{"year":2020,"claim":"Discovery that EphA2 forms a complex with pendrin and controls its subcellular localization via ephrin-B2-triggered internalization established a receptor tyrosine kinase-based trafficking mechanism, and identification of digenic EPHA2+SLC26A4 mutations in Pendred syndrome patients expanded the genetic architecture of the disease.","evidence":"Reciprocal co-immunoprecipitation, subcellular localization, ephrin ligand stimulation assays, patient mutation identification","pmids":["32165640"],"confidence":"High","gaps":["Downstream signaling intermediates between EphA2 and pendrin endocytosis not mapped","Whether EphA2 regulation operates in kidney intercalated cells unknown","Structural basis of pendrin–EphA2 interaction not determined"]},{"year":2022,"claim":"Comparison of single and double Slc26a4/Slc26a7 knockouts clarified that SLC26A7, not SLC26A4, is the dominant thyroid iodide transporter, relegating pendrin to a secondary role in thyroid hormonogenesis and explaining why most Pendred syndrome patients are euthyroid or only mildly hypothyroid.","evidence":"Slc26a4−/−, Slc26a7−/−, and double-null mice on normal and low-iodine diets; growth, thyroid hormone levels, RNA-seq","pmids":["35788623"],"confidence":"High","gaps":["Whether SLC26A4 and SLC26A7 have distinct apical vs. basolateral roles in thyrocytes not resolved","Iodine diet interaction with SLC26A4 in humans not tested"]},{"year":null,"claim":"Key unresolved questions include the high-resolution structure of pendrin (no experimentally determined structure to date), the precise signaling cascades linking aldosterone/angiotensin II to pendrin trafficking in kidney, the mechanism by which endolymphatic sac pendrin remotely controls cochlear endolymph composition, and whether chaperone-based or gene therapy approaches can be translated to postnatal treatment windows.","evidence":"","pmids":[],"confidence":"Low","gaps":["No experimentally determined 3D structure of pendrin","Signaling intermediates for hormonal regulation of renal pendrin trafficking unknown","Postnatal therapeutic window for inner ear rescue not established"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[3,5,6,10,11]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[1,3,5,6,7,12]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[5,7,9]}],"pathway":[{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[1,3,6,10,11]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[21,22]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[5,6,12,15]}],"complexes":[],"partners":["EPHA2","FOXI1","DNAJC14"],"other_free_text":[]},"mechanistic_narrative":"SLC26A4 (pendrin) is an apical membrane anion exchanger (Cl⁻/HCO₃⁻/I⁻) that maintains fluid and ion homeostasis in the inner ear, kidney, and thyroid. In the inner ear, pendrin activity specifically in the endolymphatic sac is required for the embryonic Na⁺-to-K⁺ endolymph transition, endocochlear potential generation, and normal cochlear and vestibular development; loss of pendrin causes enlarged vestibular aqueduct and sensorineural hearing loss (DFNB4/Pendred syndrome) [PMID:23874234, PMID:23741519, PMID:24561068]. In the kidney, pendrin is the exclusive apical HCO₃⁻ secretion pathway of type B intercalated cells, regulated by aldosterone, angiotensin II, and acid–base status, and is required for mineralocorticoid-induced NaCl retention and blood pressure elevation [PMID:12925556, PMID:22116363]. Most pathogenic missense mutations cause ER retention due to protein misfolding—correctable by low temperature or chaperone (DNAJC14) upregulation—while transcription of SLC26A4 depends on a FOXI1-binding promoter element, and pendrin surface trafficking is controlled by an EphA2-containing protein complex [PMID:18310264, PMID:17503324, PMID:32165640, PMID:31909090]."},"prefetch_data":{"uniprot":{"accession":"O43511","full_name":"Pendrin","aliases":["Sodium-independent chloride/iodide transporter","Solute carrier family 26 member 4"],"length_aa":780,"mass_kda":85.7,"function":"Sodium-independent transporter of chloride and iodide (PubMed:10192399, PubMed:11932316, PubMed:12107249, PubMed:16684826, PubMed:24051746). Mediates electroneutral chloride-bicarbonate, chloride-iodide and chloride-formate exchange with 1:1 stoichiometry (PubMed:10644529, PubMed:15155570, PubMed:24051746, PubMed:35601831). Mediates electroneutral iodide-bicarbonate exchange (By similarity)","subcellular_location":"Cell membrane; Apical cell membrane","url":"https://www.uniprot.org/uniprotkb/O43511/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SLC26A4","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SLC26A4","total_profiled":1310},"omim":[{"mim_id":"620874","title":"ADHESION G PROTEIN-COUPLED RECEPTOR F5; ADGRF5","url":"https://www.omim.org/entry/620874"},{"mim_id":"620437","title":"TRANSMEMBRANE p24 TRAFFICKING PROTEIN 3; TMED3","url":"https://www.omim.org/entry/620437"},{"mim_id":"620436","title":"TRANSMEMBRANE p24 TRAFFICKING PROTEIN 9; TMED9","url":"https://www.omim.org/entry/620436"},{"mim_id":"619642","title":"TRANSMEMBRANE p24 TRAFFICKING PROTEIN 2; TMED2","url":"https://www.omim.org/entry/619642"},{"mim_id":"609893","title":"HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 3; CHNG3","url":"https://www.omim.org/entry/609893"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"thyroid gland","ntpm":247.4}],"url":"https://www.proteinatlas.org/search/SLC26A4"},"hgnc":{"alias_symbol":["PDS"],"prev_symbol":["DFNB4"]},"alphafold":{"accession":"O43511","domains":[{"cath_id":"-","chopping":"84-166_181-512","consensus_level":"high","plddt":87.9042,"start":84,"end":512},{"cath_id":"3.30.750.24","chopping":"519-573_654-735","consensus_level":"high","plddt":90.333,"start":519,"end":735},{"cath_id":"1.20.5","chopping":"742-780","consensus_level":"medium","plddt":50.0803,"start":742,"end":780}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O43511","model_url":"https://alphafold.ebi.ac.uk/files/AF-O43511-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O43511-F1-predicted_aligned_error_v6.png","plddt_mean":82.75},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SLC26A4","jax_strain_url":"https://www.jax.org/strain/search?query=SLC26A4"},"sequence":{"accession":"O43511","fasta_url":"https://rest.uniprot.org/uniprotkb/O43511.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O43511/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O43511"}},"corpus_meta":[{"pmid":"10449762","id":"PMC_10449762","title":"Expression pattern of the mouse ortholog of the Pendred's syndrome gene (Pds) suggests a key role for pendrin in the inner ear.","date":"1999","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10449762","citation_count":243,"is_preprint":false},{"pmid":"11317356","id":"PMC_11317356","title":"Pendred syndrome, DFNB4, and PDS/SLC26A4 identification of eight novel mutations and possible genotype-phenotype correlations.","date":"2001","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/11317356","citation_count":234,"is_preprint":false},{"pmid":"12925556","id":"PMC_12925556","title":"Deoxycorticosterone upregulates PDS (Slc26a4) in mouse kidney: role of pendrin in mineralocorticoid-induced hypertension.","date":"2003","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/12925556","citation_count":179,"is_preprint":false},{"pmid":"9618167","id":"PMC_9618167","title":"Molecular analysis of the PDS gene in Pendred syndrome.","date":"1998","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9618167","citation_count":178,"is_preprint":false},{"pmid":"17503324","id":"PMC_17503324","title":"Transcriptional control of SLC26A4 is involved in Pendred syndrome and nonsyndromic enlargement of vestibular aqueduct (DFNB4).","date":"2007","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17503324","citation_count":163,"is_preprint":false},{"pmid":"25999548","id":"PMC_25999548","title":"Ethnic-specific spectrum of GJB2 and SLC26A4 mutations: their origin and a literature review.","date":"2015","source":"The Annals of otology, rhinology, and laryngology","url":"https://pubmed.ncbi.nlm.nih.gov/25999548","citation_count":93,"is_preprint":false},{"pmid":"24599119","id":"PMC_24599119","title":"Mutation spectrum and genotype-phenotype correlation of hearing loss patients caused by SLC26A4 mutations in the Japanese: a large cohort study.","date":"2014","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24599119","citation_count":90,"is_preprint":false},{"pmid":"19017801","id":"PMC_19017801","title":"Functional assessment of allelic variants in the SLC26A4 gene involved in Pendred syndrome and nonsyndromic EVA.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19017801","citation_count":90,"is_preprint":false},{"pmid":"18310264","id":"PMC_18310264","title":"Heterogeneity in the processing defect of SLC26A4 mutants.","date":"2008","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18310264","citation_count":88,"is_preprint":false},{"pmid":"17690912","id":"PMC_17690912","title":"Genotype-phenotype correlations for SLC26A4-related deafness.","date":"2007","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17690912","citation_count":84,"is_preprint":false},{"pmid":"8541853","id":"PMC_8541853","title":"Linkage of congenital, recessive deafness (DFNB4) to chromosome 7q31 and evidence for genetic heterogeneity in the Middle Eastern Druze population.","date":"1995","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8541853","citation_count":81,"is_preprint":false},{"pmid":"19287372","id":"PMC_19287372","title":"SLC26A4 mutation spectrum associated with DFNB4 deafness and Pendred's syndrome in Pakistanis.","date":"2009","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19287372","citation_count":80,"is_preprint":false},{"pmid":"19608655","id":"PMC_19608655","title":"Functional characterization of wild-type and mutated pendrin (SLC26A4), the anion transporter involved in Pendred syndrome.","date":"2009","source":"Journal of molecular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/19608655","citation_count":77,"is_preprint":false},{"pmid":"23185506","id":"PMC_23185506","title":"Molecular epidemiology and functional assessment of novel allelic variants of SLC26A4 in non-syndromic hearing loss patients with enlarged vestibular aqueduct in China.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23185506","citation_count":74,"is_preprint":false},{"pmid":"18274916","id":"PMC_18274916","title":"GJB2, SLC26A4 and mitochondrial DNA A1555G mutations in prelingual deafness in Northern Chinese subjects.","date":"2008","source":"Acta oto-laryngologica","url":"https://pubmed.ncbi.nlm.nih.gov/18274916","citation_count":72,"is_preprint":false},{"pmid":"32939012","id":"PMC_32939012","title":"LncRNA SLC26A4-AS1 suppresses the MRN complex-mediated DNA repair signaling and thyroid cancer metastasis by destabilizing DDX5.","date":"2020","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/32939012","citation_count":70,"is_preprint":false},{"pmid":"30193192","id":"PMC_30193192","title":"Removal of trace organic chemicals in wastewater effluent by UV/H2O2 and UV/PDS.","date":"2018","source":"Water research","url":"https://pubmed.ncbi.nlm.nih.gov/30193192","citation_count":70,"is_preprint":false},{"pmid":"19509082","id":"PMC_19509082","title":"Distinct and novel SLC26A4/Pendrin mutations in Chinese and U.S. patients with nonsyndromic hearing loss.","date":"2009","source":"Physiological genomics","url":"https://pubmed.ncbi.nlm.nih.gov/19509082","citation_count":54,"is_preprint":false},{"pmid":"19040761","id":"PMC_19040761","title":"Molecular etiology of hearing impairment in Inner Mongolia: mutations in SLC26A4 gene and relevant phenotype analysis.","date":"2008","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/19040761","citation_count":53,"is_preprint":false},{"pmid":"23874234","id":"PMC_23874234","title":"SLC26A4 targeted to the endolymphatic sac rescues hearing and balance in Slc26a4 mutant mice.","date":"2013","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23874234","citation_count":51,"is_preprint":false},{"pmid":"31695761","id":"PMC_31695761","title":"Gene therapy for hereditary hearing loss by SLC26A4 mutations in mice reveals distinct functional roles of pendrin in normal hearing.","date":"2019","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/31695761","citation_count":51,"is_preprint":false},{"pmid":"12727855","id":"PMC_12727855","title":"Hypermethylation of the Pendred syndrome gene SLC26A4 is an early event in thyroid tumorigenesis.","date":"2003","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/12727855","citation_count":51,"is_preprint":false},{"pmid":"14560015","id":"PMC_14560015","title":"Caenorhabditis elegans EVL-14/PDS-5 and SCC-3 are essential for sister chromatid cohesion in meiosis and mitosis.","date":"2003","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/14560015","citation_count":48,"is_preprint":false},{"pmid":"21961810","id":"PMC_21961810","title":"Extremely discrepant mutation spectrum of SLC26A4 between Chinese patients with isolated Mondini deformity and enlarged vestibular aqueduct.","date":"2011","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/21961810","citation_count":44,"is_preprint":false},{"pmid":"32255252","id":"PMC_32255252","title":"Long non coding RNA SLC26A4-AS1 exerts antiangiogenic effects in human glioma by upregulating NPTX1 via NFKB1 transcriptional factor.","date":"2020","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/32255252","citation_count":43,"is_preprint":false},{"pmid":"24007330","id":"PMC_24007330","title":"Correlation between genotype and phenotype in patients with bi-allelic SLC26A4 mutations.","date":"2013","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24007330","citation_count":43,"is_preprint":false},{"pmid":"21811566","id":"PMC_21811566","title":"Establishment of a knock-in mouse model with the SLC26A4 c.919-2A>G mutation and characterization of its pathology.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21811566","citation_count":43,"is_preprint":false},{"pmid":"26397989","id":"PMC_26397989","title":"Long-Term Cochlear Implant Outcomes in Children with GJB2 and SLC26A4 Mutations.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26397989","citation_count":43,"is_preprint":false},{"pmid":"20621367","id":"PMC_20621367","title":"Screening of SLC26A4, FOXI1 and KCNJ10 genes in unilateral hearing impairment with ipsilateral enlarged vestibular aqueduct.","date":"2010","source":"International journal of pediatric otorhinolaryngology","url":"https://pubmed.ncbi.nlm.nih.gov/20621367","citation_count":42,"is_preprint":false},{"pmid":"32398038","id":"PMC_32398038","title":"Generation of transgene-free PDS mutants in potato by Agrobacterium-mediated transformation.","date":"2020","source":"BMC biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/32398038","citation_count":41,"is_preprint":false},{"pmid":"31633822","id":"PMC_31633822","title":"Association of SLC26A4 mutations, morphology, and hearing in pendred syndrome and NSEVA.","date":"2019","source":"The Laryngoscope","url":"https://pubmed.ncbi.nlm.nih.gov/31633822","citation_count":39,"is_preprint":false},{"pmid":"24561068","id":"PMC_24561068","title":"Slc26a4-insufficiency causes fluctuating hearing loss and stria vascularis dysfunction.","date":"2014","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/24561068","citation_count":39,"is_preprint":false},{"pmid":"32165640","id":"PMC_32165640","title":"Digenic inheritance of mutations in EPHA2 and SLC26A4 in Pendred syndrome.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/32165640","citation_count":39,"is_preprint":false},{"pmid":"16144965","id":"PMC_16144965","title":"Intercalated cell H+/OH- transporter expression is reduced in Slc26a4 null mice.","date":"2005","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16144965","citation_count":36,"is_preprint":false},{"pmid":"23965030","id":"PMC_23965030","title":"Lack of significant association between mutations of KCNJ10 or FOXI1 and SLC26A4 mutations in Pendred syndrome/enlarged vestibular aqueducts.","date":"2013","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23965030","citation_count":36,"is_preprint":false},{"pmid":"16914891","id":"PMC_16914891","title":"Fast fluorometric method for measuring pendrin (SLC26A4) Cl-/I- transport activity.","date":"2006","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/16914891","citation_count":35,"is_preprint":false},{"pmid":"10571950","id":"PMC_10571950","title":"Splice-site mutation in the PDS gene may result in intrafamilial variability for deafness in Pendred syndrome.","date":"1999","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/10571950","citation_count":33,"is_preprint":false},{"pmid":"20597900","id":"PMC_20597900","title":"Spectrum and frequency of SLC26A4 mutations among Czech patients with early hearing loss with and without Enlarged Vestibular Aqueduct (EVA).","date":"2010","source":"Annals of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20597900","citation_count":33,"is_preprint":false},{"pmid":"12727986","id":"PMC_12727986","title":"PDS is a new susceptibility gene to autoimmune thyroid diseases: association and linkage study.","date":"2003","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/12727986","citation_count":30,"is_preprint":false},{"pmid":"23296490","id":"PMC_23296490","title":"The effect of GJB2 and SLC26A4 gene mutations on rehabilitative outcomes in pediatric cochlear implant patients.","date":"2013","source":"European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery","url":"https://pubmed.ncbi.nlm.nih.gov/23296490","citation_count":30,"is_preprint":false},{"pmid":"19786220","id":"PMC_19786220","title":"Mutation analysis of SLC26A4 in mainland Chinese patients with enlarged vestibular aqueduct.","date":"2009","source":"Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery","url":"https://pubmed.ncbi.nlm.nih.gov/19786220","citation_count":30,"is_preprint":false},{"pmid":"22116363","id":"PMC_22116363","title":"The anion exchanger pendrin (SLC26A4) and renal acid-base homeostasis.","date":"2011","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/22116363","citation_count":29,"is_preprint":false},{"pmid":"22701767","id":"PMC_22701767","title":"Genetic Screening of GJB2 and SLC26A4 in Korean Cochlear Implantees: Experience of Soree Ear Clinic.","date":"2012","source":"Clinical and experimental otorhinolaryngology","url":"https://pubmed.ncbi.nlm.nih.gov/22701767","citation_count":29,"is_preprint":false},{"pmid":"18813951","id":"PMC_18813951","title":"Identification of SLC26A4 gene mutations in Iranian families with hereditary hearing impairment.","date":"2008","source":"European journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/18813951","citation_count":28,"is_preprint":false},{"pmid":"19289392","id":"PMC_19289392","title":"Do mutations of the Pendred syndrome gene, SLC26A4, confer resistance to asthma and hypertension?","date":"2009","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19289392","citation_count":28,"is_preprint":false},{"pmid":"22412181","id":"PMC_22412181","title":"Screening of SLC26A4, FOXI1, KCNJ10, and GJB2 in bilateral deafness patients with inner ear malformation.","date":"2012","source":"Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery","url":"https://pubmed.ncbi.nlm.nih.gov/22412181","citation_count":28,"is_preprint":false},{"pmid":"24105851","id":"PMC_24105851","title":"Subgroups of enlarged vestibular aqueduct in relation to SLC26A4 mutations and hearing loss.","date":"2013","source":"The Laryngoscope","url":"https://pubmed.ncbi.nlm.nih.gov/24105851","citation_count":27,"is_preprint":false},{"pmid":"24860705","id":"PMC_24860705","title":"Mutation analysis of the SLC26A4, FOXI1 and KCNJ10 genes in individuals with congenital hearing loss.","date":"2014","source":"PeerJ","url":"https://pubmed.ncbi.nlm.nih.gov/24860705","citation_count":26,"is_preprint":false},{"pmid":"31599023","id":"PMC_31599023","title":"Systematic quantification of the anion transport function of pendrin (SLC26A4) and its disease-associated variants.","date":"2019","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/31599023","citation_count":25,"is_preprint":false},{"pmid":"31971949","id":"PMC_31971949","title":"Computational analysis of functional single nucleotide polymorphisms associated with SLC26A4 gene.","date":"2020","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/31971949","citation_count":25,"is_preprint":false},{"pmid":"31592162","id":"PMC_31592162","title":"Silencing of the phytoene desaturase (PDS) gene affects the expression of fruit-ripening genes in tomatoes.","date":"2019","source":"Plant methods","url":"https://pubmed.ncbi.nlm.nih.gov/31592162","citation_count":24,"is_preprint":false},{"pmid":"15279074","id":"PMC_15279074","title":"Mutations in the SLC26A4 (pendrin) gene in patients with sensorineural deafness and enlarged vestibular aqueduct.","date":"2004","source":"Journal of endocrinological investigation","url":"https://pubmed.ncbi.nlm.nih.gov/15279074","citation_count":24,"is_preprint":false},{"pmid":"31556116","id":"PMC_31556116","title":"Overexpression of long noncoding RNA SLC26A4-AS1 inhibits the epithelial-mesenchymal transition via the MAPK pathway in papillary thyroid carcinoma.","date":"2019","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/31556116","citation_count":23,"is_preprint":false},{"pmid":"34378314","id":"PMC_34378314","title":"Overexpression of lncRNA SLC26A4-AS1 inhibits papillary thyroid carcinoma progression through recruiting ETS1 to promote ITPR1-mediated autophagy.","date":"2021","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34378314","citation_count":23,"is_preprint":false},{"pmid":"25493717","id":"PMC_25493717","title":"Prevalence of mutations in GJB2, SLC26A4, and mtDNA in children with severe or profound sensorineural hearing loss in southwestern China.","date":"2015","source":"Genetic testing and molecular biomarkers","url":"https://pubmed.ncbi.nlm.nih.gov/25493717","citation_count":23,"is_preprint":false},{"pmid":"31228605","id":"PMC_31228605","title":"A systematic review of SLC26A4 mutations causing hearing loss in the Iranian population.","date":"2019","source":"International journal of pediatric otorhinolaryngology","url":"https://pubmed.ncbi.nlm.nih.gov/31228605","citation_count":22,"is_preprint":false},{"pmid":"23958391","id":"PMC_23958391","title":"A systematic review and meta-analysis of common mutations of SLC26A4 gene in Asian populations.","date":"2013","source":"International journal of pediatric otorhinolaryngology","url":"https://pubmed.ncbi.nlm.nih.gov/23958391","citation_count":22,"is_preprint":false},{"pmid":"34101619","id":"PMC_34101619","title":"Type II alveolar epithelial cell-specific loss of RhoA exacerbates allergic airway inflammation through SLC26A4.","date":"2021","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/34101619","citation_count":22,"is_preprint":false},{"pmid":"21704276","id":"PMC_21704276","title":"Mutation analysis of SLC26A4 for Pendred syndrome and nonsyndromic hearing loss by high-resolution melting.","date":"2011","source":"The Journal of molecular diagnostics : JMD","url":"https://pubmed.ncbi.nlm.nih.gov/21704276","citation_count":21,"is_preprint":false},{"pmid":"31784581","id":"PMC_31784581","title":"Prenatal electroporation-mediated gene transfer restores Slc26a4 knock-out mouse hearing and vestibular function.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31784581","citation_count":20,"is_preprint":false},{"pmid":"24051746","id":"PMC_24051746","title":"Use of SLC26A4 mutation testing for unilateral enlargement of the vestibular aqueduct.","date":"2013","source":"JAMA otolaryngology-- head & neck surgery","url":"https://pubmed.ncbi.nlm.nih.gov/24051746","citation_count":20,"is_preprint":false},{"pmid":"31124793","id":"PMC_31124793","title":"The Effects of GJB2 or SLC26A4 Gene Mutations on Neural Response of the Electrically Stimulated Auditory Nerve in Children.","date":"2020","source":"Ear and hearing","url":"https://pubmed.ncbi.nlm.nih.gov/31124793","citation_count":19,"is_preprint":false},{"pmid":"11558900","id":"PMC_11558900","title":"Genetic features of hearing loss associated with ear anomalies: PDS and EYA1 mutation analysis.","date":"2001","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11558900","citation_count":19,"is_preprint":false},{"pmid":"26900070","id":"PMC_26900070","title":"Vestibular function is associated with residual low-frequency hearing loss in patients with bi-allelic mutations in the SLC26A4 gene.","date":"2016","source":"Hearing research","url":"https://pubmed.ncbi.nlm.nih.gov/26900070","citation_count":19,"is_preprint":false},{"pmid":"32645618","id":"PMC_32645618","title":"The mutation frequencies of GJB2, GJB3, SLC26A4 and MT-RNR1 of patients with severe to profound sensorineural hearing loss in northwest China.","date":"2020","source":"International journal of pediatric otorhinolaryngology","url":"https://pubmed.ncbi.nlm.nih.gov/32645618","citation_count":18,"is_preprint":false},{"pmid":"28964290","id":"PMC_28964290","title":"Novel pathogenic variants underlie SLC26A4-related hearing loss in a multiethnic cohort.","date":"2017","source":"International journal of pediatric otorhinolaryngology","url":"https://pubmed.ncbi.nlm.nih.gov/28964290","citation_count":18,"is_preprint":false},{"pmid":"23273637","id":"PMC_23273637","title":"Molecular analysis of SLC26A4 gene in patients with nonsyndromic hearing loss and EVA: identification of two novel mutations in Brazilian patients.","date":"2012","source":"International journal of pediatric otorhinolaryngology","url":"https://pubmed.ncbi.nlm.nih.gov/23273637","citation_count":18,"is_preprint":false},{"pmid":"24804242","id":"PMC_24804242","title":"Associations between GJB2, mitochondrial 12S rRNA, SLC26A4 mutations, and hearing loss among three ethnicities.","date":"2014","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/24804242","citation_count":18,"is_preprint":false},{"pmid":"24737404","id":"PMC_24737404","title":"Prevalence and range of GJB2 and SLC26A4 mutations in patients with autosomal recessive non‑syndromic hearing loss.","date":"2014","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/24737404","citation_count":17,"is_preprint":false},{"pmid":"17697873","id":"PMC_17697873","title":"Analysis of the SLC26A4 gene in patients with Pendred syndrome in Taiwan.","date":"2007","source":"Metabolism: clinical and experimental","url":"https://pubmed.ncbi.nlm.nih.gov/17697873","citation_count":17,"is_preprint":false},{"pmid":"23741519","id":"PMC_23741519","title":"Endolymphatic Na⁺ and K⁺ concentrations during cochlear growth and enlargement in mice lacking Slc26a4/pendrin.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23741519","citation_count":17,"is_preprint":false},{"pmid":"29576941","id":"PMC_29576941","title":"Tobacco rattle virus-induced PHYTOENE DESATURASE (PDS) and Mg-chelatase H subunit (ChlH) gene silencing in Solanum pseudocapsicum L.","date":"2018","source":"PeerJ","url":"https://pubmed.ncbi.nlm.nih.gov/29576941","citation_count":17,"is_preprint":false},{"pmid":"31033086","id":"PMC_31033086","title":"Modified U1 snRNA and antisense oligonucleotides rescue splice mutations in SLC26A4 that cause hereditary hearing loss.","date":"2019","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/31033086","citation_count":17,"is_preprint":false},{"pmid":"18283249","id":"PMC_18283249","title":"Phenotypes of SLC26A4 gene mutations: Pendred syndrome and hypoacusis with enlarged vestibular aqueduct.","date":"2008","source":"Neuro endocrinology letters","url":"https://pubmed.ncbi.nlm.nih.gov/18283249","citation_count":16,"is_preprint":false},{"pmid":"18209476","id":"PMC_18209476","title":"Decreased expression of Slc26a4 (Pendrin) and Slc26a7 in the kidneys of carbonic anhydrase II-deficient mice.","date":"2008","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/18209476","citation_count":16,"is_preprint":false},{"pmid":"20690843","id":"PMC_20690843","title":"Large-pore PDS mesh compared to small-pore PG mesh.","date":"2010","source":"Journal of investigative surgery : the official journal of the Academy of Surgical Research","url":"https://pubmed.ncbi.nlm.nih.gov/20690843","citation_count":16,"is_preprint":false},{"pmid":"18427006","id":"PMC_18427006","title":"A novel SLC26A4 (PDS) deafness mutation retained in the endoplasmic reticulum.","date":"2008","source":"Archives of otolaryngology--head & neck surgery","url":"https://pubmed.ncbi.nlm.nih.gov/18427006","citation_count":15,"is_preprint":false},{"pmid":"25649612","id":"PMC_25649612","title":"GJB2 as Well as SLC26A4 Gene Mutations are Prominent Causes for Congenital Deafness.","date":"2015","source":"Cell biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/25649612","citation_count":15,"is_preprint":false},{"pmid":"24760582","id":"PMC_24760582","title":"Atrophic thyroid follicles and inner ear defects reminiscent of cochlear hypothyroidism in Slc26a4-related deafness.","date":"2014","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/24760582","citation_count":15,"is_preprint":false},{"pmid":"22796198","id":"PMC_22796198","title":"Mutational analysis of the SLC26A4 gene in Chinese sporadic nonsyndromic hearing-impaired children.","date":"2012","source":"International journal of pediatric otorhinolaryngology","url":"https://pubmed.ncbi.nlm.nih.gov/22796198","citation_count":15,"is_preprint":false},{"pmid":"20128824","id":"PMC_20128824","title":"Two missense mutations in SLC26A4 gene: a molecular and functional study.","date":"2009","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20128824","citation_count":14,"is_preprint":false},{"pmid":"34170635","id":"PMC_34170635","title":"Increased diagnosis of enlarged vestibular aqueduct by multiplex PCR enrichment and next-generation sequencing of the SLC26A4 gene.","date":"2021","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34170635","citation_count":14,"is_preprint":false},{"pmid":"25290043","id":"PMC_25290043","title":"The role and spectrum of SLC26A4 mutations in Iranian patients with autosomal recessive hereditary deafness.","date":"2014","source":"International journal of audiology","url":"https://pubmed.ncbi.nlm.nih.gov/25290043","citation_count":14,"is_preprint":false},{"pmid":"38797550","id":"PMC_38797550","title":"CRISPR/Cas9 based genome editing of Phytoene desaturase (PDS) gene in chilli pepper (Capsicum annuum L.).","date":"2024","source":"Journal, genetic engineering & biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/38797550","citation_count":14,"is_preprint":false},{"pmid":"37322474","id":"PMC_37322474","title":"Single-cell RNA-sequencing of stria vascularis cells in the adult Slc26a4-/- mouse.","date":"2023","source":"BMC medical genomics","url":"https://pubmed.ncbi.nlm.nih.gov/37322474","citation_count":13,"is_preprint":false},{"pmid":"29739340","id":"PMC_29739340","title":"Mutation analysis of SLC26A4 (Pendrin) gene in a Brazilian sample of hearing-impaired subjects.","date":"2018","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29739340","citation_count":13,"is_preprint":false},{"pmid":"26886089","id":"PMC_26886089","title":"Mutation screening of the SLC26A4 gene in a cohort of 192 Chinese patients with congenital hypothyroidism.","date":"2016","source":"Archives of endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/26886089","citation_count":13,"is_preprint":false},{"pmid":"31155292","id":"PMC_31155292","title":"A knock-in mouse model of Pendred syndrome with Slc26a4 L236P mutation.","date":"2019","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/31155292","citation_count":13,"is_preprint":false},{"pmid":"34410491","id":"PMC_34410491","title":"Exploring the missing heritability in subjects with hearing loss, enlarged vestibular aqueducts, and a single or no pathogenic SLC26A4 variant.","date":"2021","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/34410491","citation_count":13,"is_preprint":false},{"pmid":"23246836","id":"PMC_23246836","title":"A novel synonymous mutation causing complete skipping of exon 16 in the SLC26A4 gene in a Korean family with hearing loss.","date":"2012","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/23246836","citation_count":13,"is_preprint":false},{"pmid":"19179960","id":"PMC_19179960","title":"The hemicellulose preparation, Natramune (PDS-2865), increases macrophage phagocytosis and nitric oxide production and increases circulating human lymphocytes levels.","date":"2009","source":"Medical science monitor : international medical journal of experimental and clinical research","url":"https://pubmed.ncbi.nlm.nih.gov/19179960","citation_count":13,"is_preprint":false},{"pmid":"32384426","id":"PMC_32384426","title":"A phase I/IIa double blind single institute trial of low dose sirolimus for Pendred syndrome/DFNB4.","date":"2020","source":"Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32384426","citation_count":12,"is_preprint":false},{"pmid":"37064007","id":"PMC_37064007","title":"CRISPR/Cas9-mediated editing of phytoene desaturase (PDS) gene in an important staple crop, potato.","date":"2023","source":"3 Biotech","url":"https://pubmed.ncbi.nlm.nih.gov/37064007","citation_count":12,"is_preprint":false},{"pmid":"24338212","id":"PMC_24338212","title":"Intrafamilial phenotypic variability in families with biallelic SLC26A4 mutations.","date":"2013","source":"The Laryngoscope","url":"https://pubmed.ncbi.nlm.nih.gov/24338212","citation_count":12,"is_preprint":false},{"pmid":"36693481","id":"PMC_36693481","title":"Constant oxidation of atrazine in Fe(III)/PDS system by enhancing Fe(III)/Fe(II) cycle with quinones: Reaction mechanism, degradation pathway and DFT calculation.","date":"2023","source":"Chemosphere","url":"https://pubmed.ncbi.nlm.nih.gov/36693481","citation_count":11,"is_preprint":false},{"pmid":"22717225","id":"PMC_22717225","title":"Novel mutations in the SLC26A4 gene.","date":"2012","source":"International journal of pediatric otorhinolaryngology","url":"https://pubmed.ncbi.nlm.nih.gov/22717225","citation_count":11,"is_preprint":false},{"pmid":"26683941","id":"PMC_26683941","title":"Diagnostic Value of SLC26A4 Mutation Status in Hereditary Hearing Loss With EVA: A PRISMA-Compliant Meta-Analysis.","date":"2015","source":"Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26683941","citation_count":11,"is_preprint":false},{"pmid":"35788623","id":"PMC_35788623","title":"The iodide transporter Slc26a7 impacts thyroid function more strongly than Slc26a4 in mice.","date":"2022","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/35788623","citation_count":11,"is_preprint":false},{"pmid":"27240500","id":"PMC_27240500","title":"Identification of a novel mutation in SLC26A4 gene in a Chinese family with enlarged vestibular aqueduct syndrome.","date":"2016","source":"International journal of pediatric otorhinolaryngology","url":"https://pubmed.ncbi.nlm.nih.gov/27240500","citation_count":11,"is_preprint":false},{"pmid":"31909090","id":"PMC_31909090","title":"DNAJC14 Ameliorates Inner Ear Degeneration in the DFNB4 Mouse Model.","date":"2019","source":"Molecular therapy. Methods & clinical development","url":"https://pubmed.ncbi.nlm.nih.gov/31909090","citation_count":10,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":53911,"output_tokens":5738,"usd":0.123901},"stage2":{"model":"claude-opus-4-6","input_tokens":9393,"output_tokens":3437,"usd":0.199335},"total_usd":0.323236,"stage1_batch_id":"msgbatch_011rkcQdVV1RaFq9XhcG6df6","stage2_batch_id":"msgbatch_01RzgrJafdF4EWHhj5mNi6dh","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"Mouse ortholog Pds (Slc26a4) is expressed in the endolymphatic duct and sac, distinct areas of the utricle and saccule, and the external sulcus region of the cochlea—regions implicated in endolymphatic fluid resorption—establishing a key role for pendrin in inner ear fluid homeostasis.\",\n      \"method\": \"RNA in situ hybridization on mouse inner ears across developmental stages\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct localization experiment with functional consequence (endolymphatic fluid resorption), widely cited foundational study\",\n      \"pmids\": [\"10449762\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Pendrin (Slc26a4) is expressed on the apical plasma membrane of type B and non-A, non-B intercalated cells in the kidney collecting duct; deoxycorticosterone (DOCP) upregulates Pds mRNA (~60%) and apical pendrin protein (2–6-fold), and Pds-null mice fail to develop DOCP-induced hypertension or metabolic alkalosis, demonstrating that pendrin is required for mineralocorticoid-induced NaCl retention and blood pressure elevation.\",\n      \"method\": \"Quantitative RT-PCR, immunolocalization (light and electron microscopy), and physiological studies in Pds(-/-) mice treated with DOCP\",\n      \"journal\": \"Hypertension\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (molecular, protein, and whole-animal physiology) in knockout model with defined phenotypic readout\",\n      \"pmids\": [\"12925556\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Genetic disruption of Slc26a4 in mice reduces the abundance of non-A (type B and non-A, non-B) intercalated cells and decreases H⁺-ATPase, NBC3, and RhBG protein expression in the cortical collecting duct, indicating that pendrin-mediated HCO₃⁻ secretion controls intercalated cell subtype composition and H⁺/OH⁻ transporter expression to maintain acid-base balance.\",\n      \"method\": \"Balance studies, immunolocalization, and immunoblotting in Slc26a4(-/-) mice\",\n      \"journal\": \"American Journal of Physiology – Renal Physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — knockout with multiple orthogonal methods and defined cellular phenotype\",\n      \"pmids\": [\"16144965\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Pendrin (SLC26A4) mediates Cl⁻/I⁻ anion exchange across the plasma membrane; the disease-associated S28R mutant shows markedly reduced Cl⁻/I⁻ transport activity compared with wild-type pendrin.\",\n      \"method\": \"Fast fluorometric Cl⁻/I⁻ transport assay in heterologously expressing cells\",\n      \"journal\": \"Cellular Physiology and Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro transport assay with mutant, but single study\",\n      \"pmids\": [\"16914891\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"A c.−103T→C mutation in the SLC26A4 promoter abolishes FOXI1 binding and eliminates FOXI1-mediated transcriptional activation of SLC26A4; mutations in FOXI1 also compromise its ability to activate SLC26A4; double-heterozygous Slc26a4(+/−); Foxi1(+/−) mice develop EVA, establishing a dosage-dependent transcriptional regulatory pathway for SLC26A4.\",\n      \"method\": \"Reporter assays, electrophoretic mobility shift assay (FOXI1 binding), mouse double-heterozygous model with EVA phenotype readout\",\n      \"journal\": \"American Journal of Human Genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — transcriptional mechanism validated by binding assay + mouse genetics with defined phenotype\",\n      \"pmids\": [\"17503324\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Most disease-associated SLC26A4 missense mutations cause retention of pendrin in the endoplasmic reticulum or centrosomal region, abolishing complex glycosylation and Cl⁻/HCO₃⁻ exchange activity; temperature rescue (low temperature) restores processing of H723R-pendrin but not L236P-pendrin, demonstrating mutation-specific folding defects.\",\n      \"method\": \"Cellular localization (immunofluorescence/fractionation), N-glycosylation assays, Cl⁻/HCO₃⁻ exchange activity assays, low-temperature rescue experiments\",\n      \"journal\": \"Journal of Medical Genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods (localization, glycosylation, transport function, rescue), replicated across multiple mutants\",\n      \"pmids\": [\"18310264\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Functional characterization of SLC26A4 missense mutations in Xenopus oocytes revealed that addition or loss of proline or charged amino acids is detrimental to pendrin ion transport function; the E303Q mutant, despite near-normal surface expression, completely abolishes anion exchange activity, while F354S and E737D mutations selectively reduce Cl⁻/HCO₃⁻ exchange relative to Cl⁻/Cl⁻ and Cl⁻/I⁻ exchange.\",\n      \"method\": \"Anion exchange activity measured in Xenopus oocytes; surface expression quantification\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted functional assay in oocytes with multiple mutants and surface expression controls\",\n      \"pmids\": [\"19017801\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Two Tunisian disease-associated SLC26A4 mutations (L445W and M147T) abolish complex glycosylation of pendrin and prevent its trafficking to the plasma membrane, trapping it in an intracellular compartment.\",\n      \"method\": \"RT-PCR, western blot, and immunofluorescence in COS7 cells and thyroid 8305C cells transfected with wild-type or mutant SLC26A4\",\n      \"journal\": \"Clinical Genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (protein level, glycosylation, localization) in a single study\",\n      \"pmids\": [\"20128824\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Carbonic anhydrase II (CAII) deficiency reduces pendrin (Slc26a4) mRNA and protein expression in kidney cortex by ~63%, demonstrating that CAII is required for maintenance of pendrin expression in intercalated cells.\",\n      \"method\": \"Real-time RT-PCR, Northern hybridization, immunolabeling, and immunoblotting in CAII-null mice\",\n      \"journal\": \"Cellular Physiology and Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple molecular methods in knockout model, single study\",\n      \"pmids\": [\"18209476\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"A novel frameshift SLC26A4 mutation (c.1458_1459insT) produces a protein mislocalized to the ER rather than the plasma membrane in COS7 cells, as shown by YFP-fusion live imaging.\",\n      \"method\": \"Fluorescent protein (YFP) construct transfection in COS7 cells with live imaging\",\n      \"journal\": \"Archives of Otolaryngology – Head & Neck Surgery\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single method, single study, single mutation\",\n      \"pmids\": [\"18427006\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Pendrin (SLC26A4) functions as a transmembrane exchanger of Cl⁻, I⁻, and HCO₃⁻; functional assays of missense mutations confirmed that most disease alleles substantially reduce anion transport, with the severity correlating with structural changes such as proline insertion/deletion or charge alterations.\",\n      \"method\": \"Radioisotope-based transport assays and confocal microscopy for membrane expression in heterologous expression system\",\n      \"journal\": \"Journal of Molecular Endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 — functional transport assays across multiple mutants, summary of multiple studies\",\n      \"pmids\": [\"19608655\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"In Slc26a4-null mice, pendrin-mediated luminal Cl⁻/HCO₃⁻ exchange is the exclusive apical bicarbonate-secreting pathway in type B intercalated cells; its expression and activity are regulated by systemic acid-base status, dietary chloride, angiotensin II, and aldosterone through changes in subcellular localization, cell abundance, and total protein level.\",\n      \"method\": \"Genetic ablation (Slc26a4 knockout mouse), immunolocalization, and acid-base physiological studies\",\n      \"journal\": \"Cellular Physiology and Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — knockout with defined cellular phenotype, multiple regulatory mechanisms established, replicated across labs\",\n      \"pmids\": [\"22116363\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Most SLC26A4 variant pendrins tested in Chinese patients with EVA cause retention of the protein in intracellular compartments rather than delivery to the plasma membrane, resulting in significantly reduced anion transport capability.\",\n      \"method\": \"Confocal microscopy for membrane expression and radioisotope transport assays in heterologous expression system\",\n      \"journal\": \"PLoS One\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 — functional transport and localization assays across 10 variants, single lab\",\n      \"pmids\": [\"23185506\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Restoration of SLC26A4/pendrin expression specifically in the endolymphatic sac (using ATP6V1B1 promoter-driven transgene) is sufficient to rescue normal endocochlear potential, pH gradients, otoconia formation, and hearing and balance in Slc26a4-null mice, demonstrating that pendrin activity in the endolymphatic sac is the critical site for inner ear development.\",\n      \"method\": \"Transgenic mouse complementation (endolymphatic sac-targeted expression in Slc26a4(Δ/Δ) background), auditory/vestibular physiology, endocochlear potential measurements, pH measurements, immunohistochemistry\",\n      \"journal\": \"PLoS Genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — rigorous gain-of-function rescue in KO mice with multiple physiological readouts\",\n      \"pmids\": [\"23874234\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"In embryonic Slc26a4(Δ/Δ) cochlea, endolymph is initially Na⁺-rich (~141 mM) and transitions to K⁺-rich fluid before birth; pendrin loss delays this K⁺ rise by ~3 days, linking disrupted Na⁺ transport to endolymphatic sac enlargement.\",\n      \"method\": \"Double-barreled ion-selective electrode measurements of endolymph Na⁺ and K⁺, quantitative RT-PCR and immunohistochemistry for ion transporters in Slc26a4(Δ/Δ) vs. Slc26a4(Δ/+) mice\",\n      \"journal\": \"PLoS One\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct ion measurement in KO vs. heterozygous mice with transporter expression data; single lab\",\n      \"pmids\": [\"23741519\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Residual anion exchange activity and surface expression ratio of pendrin are higher for the T410M mutant than the H723R mutant; patients with c.919-2A>G homozygous mutations produce a small amount of normal pendrin transcript (6–17% of normal), and these differences correlate with better residual hearing, establishing a genotype–function–phenotype relationship.\",\n      \"method\": \"Quantitative PCR for transcript levels, surface expression ratio assay, anion exchange activity assay in transfected cells\",\n      \"journal\": \"Clinical Genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional assays correlating with clinical phenotype, single lab\",\n      \"pmids\": [\"24007330\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Slc26a4-insufficient mice (with limited embryonic pendrin expression then withdrawn) develop fluctuating hearing loss and degeneration of stria vascularis intermediate cells, with hearing threshold fluctuations correlating with endocochlear potential fluctuations, establishing that pendrin insufficiency causes stria vascularis dysfunction and fluctuating hearing.\",\n      \"method\": \"Doxycycline-controlled transgenic mouse model, auditory brainstem response, endocochlear potential measurements, histology of stria vascularis\",\n      \"journal\": \"Neurobiology of Disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — controlled hypomorphic mouse model with direct electrophysiological and histological readouts\",\n      \"pmids\": [\"24561068\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"A systematic doxycycline dosage-dependent transport assay in HEK293T stable lines expressing pendrin missense variants in a 96-well format quantitatively distinguished loss-of-function from functional variants; several putative missense variants were found to disrupt mRNA splicing rather than protein function directly.\",\n      \"method\": \"Stable HEK293T cell lines with doxycycline-inducible expression of pendrin variants; high-throughput anion transport assay; splicing analysis\",\n      \"journal\": \"Human Mutation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic reconstitution and functional assay across many variants with doxycycline dose-response\",\n      \"pmids\": [\"31599023\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Local gene delivery (viral vector with Slc26a4 cDNA) to embryonic day 12.5 otocysts of Slc26a4 knockout and knock-in mice restored hearing but not vestibular function, demonstrating distinct spatial requirements for pendrin in cochlear vs. vestibular development.\",\n      \"method\": \"Recombinant viral vector-mediated otocyst transfection, auditory brainstem response, vestibular function testing in pendrin-deficient mice\",\n      \"journal\": \"Theranostics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo gene therapy in KO/KI mice with defined functional readouts, single lab\",\n      \"pmids\": [\"31695761\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Modified U1 snRNA rescues aberrant splicing caused by 11 of 17 SLC26A4 splice-site mutations tested in minigene assays; for three cryptic splice mutations, co-application of modified U1 snRNA and antisense oligonucleotides restored normal splicing, demonstrating that these mutations disrupt U1 snRNA recognition at 5' splice donor sites.\",\n      \"method\": \"Minigene splicing assays, modified U1 snRNA transfection, antisense oligonucleotide rescue experiments\",\n      \"journal\": \"Human Mutation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 — functional splicing assays with mechanistic rescue across multiple mutations, single lab\",\n      \"pmids\": [\"31033086\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"The chaperonin DNAJC14, activated via JEV inoculation in vitro, rescues surface expression and anion exchange activity of H723R-pendrin; DNAJC14 overexpression in H723R-pendrin transgenic mice reduces cochlear hydrops and preserves outer hair cells and stria vascularis thickness with increased KCNJ10 expression, confirming that H723R causes a protein-folding defect correctable by chaperone upregulation.\",\n      \"method\": \"In vitro DNAJC14 activation assay, H723R-pendrin transgenic mice crossed with DNAJC14-overexpressing mice, cochlear histology, KCNJ10 immunostaining\",\n      \"journal\": \"Molecular Therapy: Methods & Clinical Development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro and in vivo rescue experiments with defined molecular and cellular readouts, single lab\",\n      \"pmids\": [\"31909090\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"EphA2 forms a protein complex with pendrin and controls pendrin's subcellular localization; this interaction is disrupted by pathogenic pendrin mutations. Digenic mutations in EPHA2 (causing amino acid substitutions) in combination with monoallelic SLC26A4 mutations cause Pendred syndrome; EphA2 mutants attenuate ephrin-B2-triggered internalization of pendrin while sparing ephrin-A1-induced internalization.\",\n      \"method\": \"Co-immunoprecipitation (pendrin–EphA2 complex), subcellular localization studies, patient mutation identification, ephrin ligand stimulation assays\",\n      \"journal\": \"Nature Communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP establishing complex, functional localization assay, patient genetics, multiple orthogonal methods\",\n      \"pmids\": [\"32165640\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"AT2 cell-specific deletion of RhoA upregulates Slc26a4 (pendrin) expression in mouse lungs; SLC26A4 upregulation is also found in AT2 cells of asthmatic patients and in human airway epithelial cells expressing dominant-negative RHOA; SLC26A4 inhibition promotes epithelial TGF-β1 release and attenuates allergic airway inflammation, placing SLC26A4 downstream of RhoA in a pathway controlling TGF-β1 secretion and airway inflammation.\",\n      \"method\": \"Conditional AT2-specific RhoA KO mice, allergen challenge model, RNA sequencing, dominant-negative RHOA overexpression in human cells, SLC26A4 inhibition experiments\",\n      \"journal\": \"JCI Insight\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis via conditional KO plus human cell mechanistic follow-up, single lab\",\n      \"pmids\": [\"34101619\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Slc26a7-null mice show goitrous congenital hypothyroidism and marked growth failure; Slc26a4-null mice show no growth failure or hypothyroidism under low-iodine conditions; double-deficient mice are more severely affected than Slc26a7-null mice, and RNA-seq shows far more differentially expressed genes in Slc26a7-null than Slc26a4-null thyroid, demonstrating that SLC26A7 is the dominant iodide transporter for thyroid function while SLC26A4 plays a secondary role.\",\n      \"method\": \"Slc26a4-null, Slc26a7-null, and double-null mouse models under normal and low-iodine diet; growth/hormone measurements; RNA-seq\",\n      \"journal\": \"Scientific Reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — systematic comparison across single and double KO mice with physiological and transcriptomic readouts\",\n      \"pmids\": [\"35788623\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SLC26A4 (pendrin) is a membrane anion exchanger (Cl⁻/HCO₃⁻/I⁻) localized to the apical membrane of thyroid follicular cells, renal type B and non-A/non-B intercalated cells, and endolymphatic sac/cochlear epithelium; its activity in the endolymphatic sac is required for normal endolymph Na⁺→K⁺ transition and inner ear development, its transcription is controlled by FOXI1 binding to a promoter element, its subcellular trafficking is regulated by EphA2 and chaperones such as DNAJC14, and most pathogenic mutations cause ER retention/misfolding that abolishes anion transport, leading to hearing loss (DFNB4/Pendred syndrome) and, in the kidney, impaired mineralocorticoid-induced NaCl retention and blood pressure regulation.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"SLC26A4 (pendrin) is an apical membrane anion exchanger (Cl⁻/HCO₃⁻/I⁻) that maintains fluid and ion homeostasis in the inner ear, kidney, and thyroid. In the inner ear, pendrin activity specifically in the endolymphatic sac is required for the embryonic Na⁺-to-K⁺ endolymph transition, endocochlear potential generation, and normal cochlear and vestibular development; loss of pendrin causes enlarged vestibular aqueduct and sensorineural hearing loss (DFNB4/Pendred syndrome) [PMID:23874234, PMID:23741519, PMID:24561068]. In the kidney, pendrin is the exclusive apical HCO₃⁻ secretion pathway of type B intercalated cells, regulated by aldosterone, angiotensin II, and acid–base status, and is required for mineralocorticoid-induced NaCl retention and blood pressure elevation [PMID:12925556, PMID:22116363]. Most pathogenic missense mutations cause ER retention due to protein misfolding—correctable by low temperature or chaperone (DNAJC14) upregulation—while transcription of SLC26A4 depends on a FOXI1-binding promoter element, and pendrin surface trafficking is controlled by an EphA2-containing protein complex [PMID:18310264, PMID:17503324, PMID:32165640, PMID:31909090].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Establishing where pendrin acts in the inner ear resolved why SLC26A4 mutations cause hearing loss: expression mapped to the endolymphatic duct/sac and cochlear external sulcus—sites of endolymph resorption—linking the transporter to fluid homeostasis rather than sensory transduction per se.\",\n      \"evidence\": \"RNA in situ hybridization across developmental stages in mouse inner ears\",\n      \"pmids\": [\"10449762\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No functional transport data at this stage\", \"Expression in non-inner-ear tissues not yet characterized\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Demonstrating that Pds-null mice resist mineralocorticoid-induced hypertension and metabolic alkalosis established a renal role for pendrin distinct from its inner ear function: pendrin mediates apical Cl⁻/HCO₃⁻ exchange in type B intercalated cells and is required for NaCl retention.\",\n      \"evidence\": \"Quantitative RT-PCR, immunolocalization, and blood pressure/electrolyte physiology in DOCP-treated Pds−/− mice\",\n      \"pmids\": [\"12925556\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream signals controlling renal pendrin abundance not yet defined\", \"Whether pendrin contributes to basal (non-mineralocorticoid) blood pressure unknown\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Showing that Slc26a4 knockout alters intercalated cell subtype composition and expression of H⁺-ATPase, NBC3, and RhBG revealed that pendrin-mediated HCO₃⁻ secretion is not merely one of several pathways but the dominant apical bicarbonate exit route whose loss remodels collecting duct cell identity.\",\n      \"evidence\": \"Immunoblotting, immunolocalization, and balance studies in Slc26a4−/− mice\",\n      \"pmids\": [\"16144965\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signaling mechanism linking loss of luminal HCO₃⁻ to intercalated cell remodeling unknown\", \"Whether human CKD patients show analogous cell-type shifts unexplored\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Direct measurement of Cl⁻/I⁻ exchange in heterologous cells confirmed pendrin as a bona fide anion exchanger and showed the first disease-associated mutant (S28R) with quantifiably reduced transport, establishing the functional assay framework used in subsequent studies.\",\n      \"evidence\": \"Fast fluorometric Cl⁻/I⁻ transport assay in transfected cells\",\n      \"pmids\": [\"16914891\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Only one mutant tested\", \"Cl⁻/HCO₃⁻ exchange not measured in this assay\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Identification of FOXI1 as a transcription factor that binds the SLC26A4 promoter and is required for its expression, together with EVA in double-heterozygous mice, resolved how monoallelic SLC26A4 mutations can cause disease through digenic dosage-dependent transcriptional insufficiency.\",\n      \"evidence\": \"EMSA for FOXI1 binding, reporter assays, Slc26a4+/−;Foxi1+/− double-heterozygous mice with EVA phenotype\",\n      \"pmids\": [\"17503324\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Other transcription factors acting on SLC26A4 not identified\", \"Whether FOXI1 dosage explains all monoallelic SLC26A4 cases unknown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Systematic analysis of disease-associated missense mutations revealed that the dominant pathogenic mechanism is ER retention and misfolding rather than catalytic-site inactivation, with mutation-specific rescue by low temperature indicating correctable folding defects; a subset of mutations (e.g., E303Q) reach the surface but are catalytically dead, separating trafficking from transport competence.\",\n      \"evidence\": \"Immunofluorescence, N-glycosylation analysis, Cl⁻/HCO₃⁻ exchange assays, low-temperature rescue in transfected cells; anion exchange in Xenopus oocytes with surface expression quantification\",\n      \"pmids\": [\"18310264\", \"19017801\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for folding defects unknown (no crystal structure)\", \"Endogenous chaperones involved not yet identified\", \"Whether ER-retained pendrin triggers UPR or is degraded by ERAD not tested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Integrating knockout physiology with hormonal regulation demonstrated that pendrin expression and apical targeting in kidney are dynamically controlled by aldosterone, angiotensin II, dietary Cl⁻, and acid–base status, positioning pendrin as a regulated effector of systemic electrolyte balance rather than a constitutive transporter.\",\n      \"evidence\": \"Slc26a4 KO mice with immunolocalization and acid–base physiological studies under varied conditions\",\n      \"pmids\": [\"22116363\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct kinase/phosphatase cascades linking aldosterone/AngII to pendrin trafficking not identified\", \"Post-translational modifications regulating pendrin unclear\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Targeted restoration of pendrin solely in the endolymphatic sac rescued hearing, balance, endocochlear potential, and otoconia in Slc26a4-null mice, proving that the endolymphatic sac—not the cochlea or vestibule—is the critical site of pendrin action for inner ear development, and that pendrin controls the embryonic Na⁺-to-K⁺ endolymph composition switch.\",\n      \"evidence\": \"Transgenic complementation (Atp6v1b1-promoter-driven Slc26a4) in null mice; endocochlear potential, pH, ion-selective electrode measurements\",\n      \"pmids\": [\"23874234\", \"23741519\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which endolymphatic sac pendrin remotely controls cochlear endolymph composition unclear\", \"Identity of downstream ion transporters affected in endolymphatic sac not fully catalogued\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"A doxycycline-controlled hypomorphic model showed that even partial pendrin insufficiency causes fluctuating hearing loss correlated with endocochlear potential instability and stria vascularis degeneration, explaining the clinical fluctuating phenotype in patients with residual SLC26A4 function.\",\n      \"evidence\": \"Doxycycline-regulated Slc26a4 transgenic mice; ABR, endocochlear potential, stria vascularis histology\",\n      \"pmids\": [\"24561068\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Threshold of pendrin activity needed to prevent fluctuating hearing loss not quantified\", \"Whether stria vascularis degeneration is reversible unknown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Multiple complementary advances addressed therapeutic correction: high-throughput functional classification of variants distinguished loss-of-function from benign alleles; modified U1 snRNA rescued splicing defects caused by 11/17 splice-site mutations; chaperone DNAJC14 overexpression rescued H723R-pendrin folding, surface expression, and cochlear pathology in vivo; and embryonic otocyst gene delivery restored hearing in KO mice.\",\n      \"evidence\": \"Doxycycline-inducible HEK293T transport assay across many variants; minigene splicing assays with U1/ASO rescue; DNAJC14-overexpressing transgenic cross with H723R mice; viral vector otocyst injection with ABR\",\n      \"pmids\": [\"31599023\", \"31033086\", \"31909090\", \"31695761\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"DNAJC14 mechanism of pendrin folding rescue not defined at structural level\", \"Gene therapy did not rescue vestibular function—spatial requirements for vestibular rescue unclear\", \"Long-term durability of gene therapy or chaperone approaches unknown\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Discovery that EphA2 forms a complex with pendrin and controls its subcellular localization via ephrin-B2-triggered internalization established a receptor tyrosine kinase-based trafficking mechanism, and identification of digenic EPHA2+SLC26A4 mutations in Pendred syndrome patients expanded the genetic architecture of the disease.\",\n      \"evidence\": \"Reciprocal co-immunoprecipitation, subcellular localization, ephrin ligand stimulation assays, patient mutation identification\",\n      \"pmids\": [\"32165640\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream signaling intermediates between EphA2 and pendrin endocytosis not mapped\", \"Whether EphA2 regulation operates in kidney intercalated cells unknown\", \"Structural basis of pendrin–EphA2 interaction not determined\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Comparison of single and double Slc26a4/Slc26a7 knockouts clarified that SLC26A7, not SLC26A4, is the dominant thyroid iodide transporter, relegating pendrin to a secondary role in thyroid hormonogenesis and explaining why most Pendred syndrome patients are euthyroid or only mildly hypothyroid.\",\n      \"evidence\": \"Slc26a4−/−, Slc26a7−/−, and double-null mice on normal and low-iodine diets; growth, thyroid hormone levels, RNA-seq\",\n      \"pmids\": [\"35788623\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether SLC26A4 and SLC26A7 have distinct apical vs. basolateral roles in thyrocytes not resolved\", \"Iodine diet interaction with SLC26A4 in humans not tested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the high-resolution structure of pendrin (no experimentally determined structure to date), the precise signaling cascades linking aldosterone/angiotensin II to pendrin trafficking in kidney, the mechanism by which endolymphatic sac pendrin remotely controls cochlear endolymph composition, and whether chaperone-based or gene therapy approaches can be translated to postnatal treatment windows.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No experimentally determined 3D structure of pendrin\", \"Signaling intermediates for hormonal regulation of renal pendrin trafficking unknown\", \"Postnatal therapeutic window for inner ear rescue not established\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [3, 5, 6, 10, 11]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [1, 3, 5, 6, 7, 12]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [5, 7, 9]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [1, 3, 6, 10, 11]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [21, 22]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [5, 6, 12, 15]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"EphA2\",\n      \"FOXI1\",\n      \"DNAJC14\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}